Market Newsdesk

BEVERLY HILLS, Calif., March 8, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on disruptive, target-directed Natural Killer (NK) cell engager immunotherapy technologies (TriKE™) for cancer, announces preclinical results for its ROR1 TriKE™ product candidate as a prospective therapy for the treatment of prostate cancer.

Tyrosine kinase transmembrane receptor ROR1 has recently been shown to be overexpressed on certain cancer cells, and appears to play a functional role in promoting migration/invasion and influencing the metastatic potential of various solid tumor cancers. Targeting ROR1 on cancer cells with TriKE™ and redirecting NK cells to attack and kill cancer cells expressing ROR1, could result in a therapeutic treatment that limits the metastatic potential and invasiveness of certain solid tumor cancers.

The ROR1 TriKE™ was evaluated in several preclinical models of prostate cancer, and was found to be effective at promoting NK cell killing of multiple prostate cancer cells including LnCAP, C4-2, PC-3, DU-145, VCaP and 22RV1. Significant NK cell activation and interferon gamma (IFNγ) production was also observed as a result of TriKE™ engagement and activation of the NK cell.

“We are pleased to report our ROR1 TriKE™ has passed this important preclinical milestone, and demonstrated effectiveness in promoting redirected and target-specific killing by NK cells,” said Anthony J. Cataldo, GT Biopharma’s Chairman and Chief Executive Officer. “We plan to evaluate the ROR1 TriKE™ in additional IND-enabling preclinical studies with the goal of transitioning to a Phase I/II clinical trial.”   

About GT Biopharma, Inc.

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE™ NK cell engager platform. The TriKE™ platform is designed to activate and redirect the target cell killing abilities of the patient’s natural killer cells (NK cells) without the need for supplemental ex vivo engineered donor or autologous NK cells, or induced pluripotent stem cells (iPSC). The Company has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE™ technology. GT Biopharma’s lead TriKE™ product candidate, GTB-3550 TriKE™, is being evaluated in a multicenter Phase I/II trial (ClinicalTrials.gov NCT03214666) for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other CD33+ hematopoietic malignancies.

Forward-Looking Statements

This press release contains certain forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict, including statements regarding the potential acquisition, the likelihood of closing the potential transaction, our clinical focus, and our current and proposed trials.  Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as “believes”, “hopes”, “intends”, “estimates”, “expects”, “projects”, “plans”, “anticipates” and variations thereof, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking.  Our forward-looking statements are not a guarantee of performance, and actual results could differ materially from those contained in or expressed by such statements.  In evaluating all such statements, we urge you to specifically consider the various risk factors identified in our Form 10-K for the fiscal year ended December 31, 2020 in the section titled “Risk Factors” in Part I, Item 1A and in our subsequent Form 10Q Quarterly filings with the Securities and Exchange Commission, any of which could cause actual results to differ materially from those indicated by our forward-looking statements.

Our forward-looking statements reflect our current views with respect to future events and are based on currently available financial, economic, scientific, and competitive data and information on current business plans.  You should not place undue reliance on our forward-looking statements, which are subject to risks and uncertainties relating to, among other things:  (i) the sufficiency of our cash position and our ongoing ability to raise additional capital to fund our operations, (ii) our ability to complete our contemplated clinical trials, or to meet the FDA’s requirements with respect to safety and efficacy, (iii) our ability to identify patients to enroll in our clinical trials in a timely fashion, (iv) our ability to achieve approval of a marketable product, (v) design, implementation and conduct of clinical trials, (vii) the results of our clinical trials, including the possibility of unfavorable clinical trial results, (vii) the market for, and marketability of, any product that is approved, (viii) the existence or development of treatments that are viewed by medical professionals or patients as superior to our products, (ix) regulatory initiatives, compliance with governmental regulations and the regulatory approval process, and social conditions, and (x) various other matters, many of which are beyond our control.  Should one or more of these risks or uncertainties develop, or should underlying assumptions prove to be incorrect, actual results may vary materially and adversely from those anticipated, believed, estimated, or otherwise indicated by our forward-looking statements.

We intend that all forward-looking statements made in this press release will be subject to the safe harbor protection of the federal securities laws pursuant to Section 27A of the Securities Act, to the extent applicable.  Except as required by law, we do not undertake any responsibility to update these forward-looking statements to take into account events or circumstances that occur after the date of this press release.  Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events which may cause actual results to differ from those expressed or implied by these forward-looking statements.

For more information, please visit www.gtbiopharma.com.

Contact:

Institutional Investors:

Julie Seidel

Stern Investor Relations, Inc.
[email protected]
212-362-1200

Investor Relations:

David Castaneda


[email protected]

414-351-9758

Media Relations:
Susan Roush
[email protected]
805-624-7624

View original content:http://www.prnewswire.com/news-releases/gt-biopharma-announces-preclinical-results-for-its-ror1-trike-as-a-treatment-for-prostate-cancer-301242002.html

SOURCE GT Biopharma, Inc.

TORONTO and CHICAGO, March 8, 2021 /PRNewswire/ – BMO Financial Group joins global festivities to mark International Women’s Day and Women’s History Month. Throughout the month of March, BMO is celebrating women and girls, and reinforcing its commitment to breaking down gender-based barriers and investing in their success.

“Today we honour the achievements of women while recognizing the need to continue eliminating barriers to women’s career advancement in the bank, and in the business community as entrepreneurs and investors,” said Mona Malone, Chief Human Resources Officer and Head of People & Culture, BMO Financial Group. “Unfortunately, women are losing ground as a result of the pandemic and women-led businesses are struggling to recover from its economic impacts. This is why BMO is deepening our commitment to women through new and continued partnerships with organizations, such as SheEO, The Prosperity Project and Plan International Canada, that share our values and align with our Purpose to Boldly Grow the Good in business and life.”

BMO Collaborates with SheEO

BMO is collaborating with SheEO to provide C$1.2 million in funding for women entrepreneurs and business owners. SheEO, a not-for-profit company which offers financial support to businesses led by women and non-binary people, is committed to reducing barriers women-owned businesses face when trying to obtain financing, and funding ventures that address sustainability issues faced worldwide. BMO’s financial commitment will allow SheEO to fund all 2021 venture applicant companies working to achieve the United Nations Sustainable Development Goals. BMO’s collaboration with SheEO aligns with the bank’s newly announced five-year diversity and representation goals, centred around creating a more inclusive society.

Girls Belong Here

To reinforce the bank’s ongoing commitment to fostering female leaders of tomorrow, David Casper, U.S. Chief Executive Officer, BMO Financial Group, welcomed a youth participant on March 2, 2021 to shadow him in his role. BMO has participated in three seat shares since announcing its renewed executive sponsorship of Plan International Canada’s Girls Belong Here program in October. Since sponsoring the program for the third consecutive year to mark International Day of the Girl 2020, youth have participated in day-long seat shares with: Antonio Novillo, Chief Information and Operations Officer, BMO Capital Markets T&O; and Erminia (Ernie) Johannson, Group Head, North American Personal and Business Banking, BMO Financial Group.

Prosperity Project

BMO is partnering with the Prosperity Project^TM, a new not-for-profit organization focusing on creating and disseminating knowledge on gender diversity and intersectionality in the senior ranks of Canadian workforces. The project fills an important need for explicitly linking women and prosperity – underscoring the economic importance of gender equality during the COVID-19 pandemic and as society recovers. It applies an intersectional lens, emphasizing the importance of both equity and foregrounding inclusivity. The Prosperity Project’s mission is aligns with both BMO’s’s Zero Barriers to Inclusion 2025 goals and its focus on driving an inclusive recovery from the pandemic.

Celebrating BIPOC Women-Owned Businesses

BMO continues to spotlight women-owned businesses through its Barriers Breakers social media content series, first launched in February as part of Black History Month. The series features women business owners from the BIPOC community, celebrating the success they’ve achieved in spite of the barriers they’ve overcome. In addition, to mark the arrival of International Women’s Day, today BMO has released a new video outlining its commitment to women business owners and removing barriers to inclusion. 

Rt. Hon. Michaëlle Jean

 Delivers Keynote Speech at BMO Event

To celebrate Black History Month and International Women’s Day and in keeping with its commitment to building a society with zero barriers to inclusion, BMO hosted a special event on February 24, 2021 with The Right Honourable Michaëlle Jean, Canada’s 27^th Governor General and the first Haitian-Canadian to hold the office, and BMO executives, including Darryl White, CEO, BMO Financial Group. The event, Building Empowerment Through a Racial and Gender Equity Lens, included a panel discussion on intersectionality and empowerment that was moderated by Deland Kamanga, Head, Global Markets, BMO Capital Markets. BMO panel participants included: Gillian Noble, COO, BMO Insurance and BMO Global Asset Management; Joanna Rotenberg, Group Head, Wealth Management; Ula Ubani, Chief Ethics & Conduct Officer; and Vanessa Lewerentz, Chief Inclusion Officer.

BMO’s efforts to foster an environment of diversity, equity and inclusion have been recognized within the bank and beyond.

• BMO is listed among Equileap’s top 100 gender-equal companies around the world in its 2021 Gender Equality Global Report & Ranking
• Leaders at BMO have been named as WXN’s Canada’s Most Powerful Women: Top 100. Most recently, Sherri Griffiths, Head, Greater Ontario, Canadian Commercial Banking in December 2020
• BMO has been included in the Bloomberg Gender-Equality Index (GEI) for the sixth year in a row
• BMO Harris Bank appeared on Forbes’ America’s Best Employers For Diversity 2020 for the second year in a row
• In 2018, BMO announced it is making C$3 billion in capital available over the next three years for Canadian women business owners
• BMO runs a dedicated website, www.bmoforwomen.com, which provides tools and educational resources for women entrepreneurs, including podcast series Bold(h)er
• The bank is committed to doubling its industry-leading support for women entrepreneurs as part of its Purpose commitments
• BMO honours the achievements of business and community women leaders through the BMO Celebrating Women Program
• In 2020, BMO committed US$300 million for small business lending to expand resources for women — Black and Latinx-owned small businesses in the U.S., as part of its BMO EMpower initiative
• BMO Harris Bank launched WMN•FINtech in 2020, a mentoring program for women-led fintech startups and the latest evolution of the BMO Harris / 1871 Innovation Program, designed to give more women entrepreneurs the opportunity to bring cutting-edge technology and products forward

About BMO Financial Group
Serving customers for 200 years and counting, BMO is a highly diversified financial services provider – the 8th largest bank, by assets, in North America. With total assets of $973 billion as of January 31, 2021, and a team of diverse and highly engaged employees, BMO provides a broad range of personal and commercial banking, wealth management and investment banking products and services to more than 12 million customers and conducts business through three operating groups: Personal and Commercial Banking, BMO Wealth Management and BMO Capital Markets.

View original content:http://www.prnewswire.com/news-releases/bmo-celebrates-international-womens-day-301242061.html

SOURCE BMO Financial Group

Formerly Indus Holdings, Inc., cannabis leader completes name change
and lays out strategy for future success

SALINAS, Calif., March 8, 2021 /PRNewswire/ — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a leading, vertically-integrated, California-focused cannabis company, has completed its previously announced corporate name change following the acquisition by Indus Holdings, Inc. of Lowell Farms. The combined company is now operating under the Lowell Farms Inc. name.

The Company’s Subordinate Voting Shares and Warrants are now trading on the Canadian Securities Exchange under the ticker symbols LOWL and LOWL.WT  and the Subordinate Voting Shares are now trading on the OTCQX under the ticker symbol LOWLF.  No action is required to be taken by existing securityholders of the Company with respect to the name change. Outstanding share and warrant certificates are not affected by the name change and do not need to be exchanged.

“We are hard at work pairing-up the best brand in cannabis with unparalleled production capabilities,” says Lowell Farms Chairman George Allen. “By combining Indus’ infrastructure and capabilities with Lowell’s brand leadership, we are building a business that has no equal in cannabis.”

Adds Lowell Farms Chief Executive Officer Mark Ainsworth: “The integration of Lowell products in our distribution network has already begun to show positive results, and we are scaling operations to meet the demand for our marquee products. We now control our own destiny and look forward to better showcasing the strength of our company in 2021 and beyond.”

ABOUT LOWELL FARMS

Lowell Farms (CSE:LOWL; OTCQX:LOWLF) is a California-based vertically-integrated cannabis company with advanced production capabilities supporting every step of the supply chain; including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. Founded in 2014 as Indus Holdings, Inc, Lowell Farms grows artisan craft cannabis with a deep love and respect for the plant and prides itself on using sustainable materials – from seed to sale – to produce an extensive portfolio of award-winning original and licensed brands, including Lowell Herb Co, Cypress Cannabis, MOON, and Kaizen Medicinals, for licensed retailers statewide.

Forward-Looking Information and Statements

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved.” The forward-looking information and forward-looking statements contained herein may include, but are not limited to, the anticipated benefits of the described acquisition, the ability of the Company to operate the acquired assets as currently contemplated and expanding and scaling its operations, the ability of the Company to successfully achieve its business objectives, including as a result of the described acquisition, and expectations for other economic, business, and/or competitive factors. There can be no assurance that such forward-looking information and statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking information and statements. This forward-looking information and statements reflect the Company’s current beliefs and are based on information currently available to the Company and on assumptions the Company believes are reasonable.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive applicable regulatory approvals to effect the acquisition of the remaining target assets and associated matters; operating and development costs; competition; changes in legislation or regulations affecting the Company; the timing and availability of external financing on acceptable terms; the available funds of the Company and the anticipated use of such funds; unforeseen liabilities in connection with the described acquisition; favorable production levels and outputs; the stability of pricing of cannabis products; the level of demand for cannabis product; the availability of third-party service providers and other inputs for the Company’s operations; lack of qualified, skilled labor or loss of key individuals; and risks and delays resulting from the COVID-19 pandemic. A description of additional assumptions used to develop such forward-looking information and a description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents, such as the Company’s annual information form filed on the SEDAR website at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement.

The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, is subject to change after such date. However, the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. 

Neither the Canadian Securities Exchange nor its Regulation Service Provider has reviewed, or accepts responsibility for the adequacy or accuracy of, the content of this news release.

View original content to download multimedia:http://www.prnewswire.com/news-releases/lowell-farms-inc-emerges-from-acquisition-with-an-eye-toward-dominance-in-californias-cannabis-industry-and-beyond-301242036.html

SOURCE Lowell Farms

SAN JOSE, Calif., March 8, 2021 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that Anixa’s Chief Executive Officer, Dr. Amit Kumar, has been invited to present at the Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC.  The conference will take place on March 17 and 18 from 9:00 am-5:00 pm ET featuring roundtable discussions with C-suite executives moderated by Maxim Research Analysts, fireside chats with live Q&A, and presentations from hundreds of issuers both domestically and internationally.

During this virtual conference, Anixa will present along with other important voices in the biotech industry.  Dr. Kumar will provide an overview of Anixa’s business and an update on the Company’s programs.  To attend the conference, sign up to become an M-Vest member here:  https://www.m-vest.com/events/2021-emerging-growth-virtual-conference.

About Anixa Biosciences, Inc.
Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease.  Anixa’s therapeutics portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a Covid-19 therapeutics program focused on inhibiting certain viral protein function.  The company’s vaccine portfolio includes a vaccine to prevent breast cancer, and specifically triple negative breast cancer (TNBC), the most deadly form of the disease, and a vaccine to prevent ovarian cancer.  These vaccine technologies focus on immunizing against specific proteins that have been found to be expressed in certain forms of cancer.  Anixa continually examines emerging technologies in complementary fields for further development and commercialization.  Additional information is available at www.anixa.com.

About M Vest LLC

M Vest LLC is an online investment bank and digital community built for issuers, investors, and thought leaders to share information and access investment opportunities through capital raisings of Regulation D and Regulation A Offerings.  Founded in 2017 and headquartered in New York City, M-Vest provides insights on current equity market trends, hosts presentations from public companies, and provides access to capital for emerging growth companies. M-Vest hosts live conferences and webinars featuring CEOs discussing the latest developments in their industries. M Vest LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC), is a member of FINRA and SIPC, and is a sister company of Maxim Group, LLC. 

About Maxim Group LLC
Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York.  The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services.  Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB).  Member of FINRA SIPC, and NASDAQ.  To learn more about Maxim Group, visit maximgrp.com.

Investor contact:
Mike Catelani
[email protected]
408-708-9808

Media contact:
Sherry Ash
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/anixa-biosciences-to-participate-in-m-vest-llc-and-maxim-group-llc-inaugural-emerging-growth-virtual-conference-301241879.html

SOURCE Anixa Biosciences, Inc.

Partnering Agreements Aim to Measure Impact of Hapbee Wearable on Veterans’ Wellbeing

(TSXV: HAPB)

VANCOUVER, BC, March 8, 2021 /PRNewswire/ – Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), a wellness technology company developing the revolutionary Hapbee wearable, is pleased to announce it has signed partnering agreements with two U.S. veteran non-profit organizations, Grey Team Inc. (“Grey Team”) and The Mission After, to enable data collection with respect to users’ perception of the impact of Hapbee signals on their stress and productivity levels within a sample group of military veterans.

“These early-stage agreements mark the beginning of what I hope will become meaningful, long-term collaborations with Grey Team and The Mission After,” said Scott Donnell, CEO of Hapbee. “Hapbee is honored to have the opportunity to engage with military veterans. The overarching goal with these agreements is to help veterans with stress management and productivity – aspects I think most all of us want to improve upon.”

Under the terms of the partnering agreements, Grey Team and The Mission After have purchased approximately twenty Hapbee wearables for veterans’ use at a discounted rate. Each Hapbee wearable will come with a lifetime subscription to all six original signals and are specifically for the purpose of R&D and user experience data collection. The partner organizations will, with users’ permission, provide Hapbee with access to users of the product to garner individual responses and feedback.

About Grey Team

Grey Team is a 501(c)(3) nonprofit organization whose sole mission is to support active-duty U.S. soldiers and military veterans by building and implementing solutions to reduce and eliminate PTSD related suicides.

Grey Team is the only privately funded program that is proven to facilitate and cultivate post-traumatic growth. It is through the generous donations of private citizens, as well as grants, that Grey Team continues to offer these therapeutic services to veterans and active duty service members at no cost. Its goal is to help those most in need of healing by providing a place where they feel welcomed and safe so that they may restore health, peace, and happiness to their lives.

About The Mission After

Based in Seattle, Washington, The Mission After (formerly known as Healing Our Heroes Foundation TMA) is a 501(c)3 nonprofit focused on research and implementation of programs that support veterans to live their best life after service. The Mission After, with the support from their strategic partner organizations, strives to provide veterans with access to new and emerging technologies as well as innovative treatment alternatives focused on pain, stress, anxiety, and depression. 

About Hapbee

Hapbee is a wearable magnetic field technology company that aims to help people choose how they feel. Powered by patented ultra-low radio frequency energy (ulRFE^®) technology invented and licensed by EMulate Therapeutics, Inc., Hapbee delivers low-power electromagnetic signals designed to produce sensations such as Happy, Alert, Focus, Relax, Calm and Sleepy.

You can learn more about how Hapbee works at www.hapbee.com/science

Forward-Looking Information Disclaimer

Certain statements included in this news release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This news release contains forward looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Any statements about the goals of the partnering agreements and future obligations thereunder; research and development and data collection by the Company and partner organizations and the sharing of access to such information; the goals and services offered by Grey Team and The Mission After and the costs thereof, are all forward-looking information. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Such statements and information are based on numerous assumptions regarding ability of the Company to receive the benefits of the partnering agreements as anticipated and the other parties to such agreements fulfilling their respective obligations; ability to successfully get consent of users for research and development and user experience data collection; and a continued working relationship with Grey Team and The Mission After.

Factors that could cause the actual results to differ materially from those in the forward-looking statements include, Grey Team or The Mission After may not fulfill some or all of their obligations under the partnering agreements; users may not provide consent to the Company to access users responses and feedback; the goal of the partnering agreements may not be realized as expected or at all; changes in legislation and regulations; increase in operating costs; equipment failures; failure of counterparties to perform their contractual obligations; litigation; the loss of key directors, employees, advisors or consultants and fees charged by service providers. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. These risks, uncertainties and assumptions include, but are not limited to, those described in Hapbee’s prospectus dated October 26, 2020, a copy of which is available on SEDAR at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company’s forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:http://www.prnewswire.com/news-releases/hapbee-partners-with-us-veteran-non-profit-organizations-grey-team-and-the-mission-after-301241846.html

SOURCE Hapbee Technologies Inc.

NEW YORK, March 8, 2021 /PRNewswire/ — Bloomberg today announced that the Bloomberg Short-Term Bank Yield Index (BSBY) is now available for use as a reference in financial benchmarks in the U.S. loan market.  BSBY includes both a term structure and systemic credit-sensitive spread, which may be used to support the market’s transition from LIBOR to risk-free rates, such as SOFR.  Bloomberg began publishing BSBY on an indicative basis for the purposes of illustration, analysis and collection of market feedback on October 15, 2020.

Over the six-month period during which BSBY was published on an indicative basis, Bloomberg received positive feedback on the sensitivity of the rate and robustness of the methodology from market participants, indicating that BSBY meets their needs as an alternative replacement rate.

“Now that BSBY is available for use in the U.S. loan market, we will continue exploring the introduction of products that may use BSBY as a benchmark,” said Steve Berkley, CEO of Bloomberg Index Services Limited (BISL). “We’re encouraged by the responses we’ve received from finanical institutions and corporations on this approach; in particular, that the availability of BSBY’s credit-sensitive rate is an important milestone in helping them move away from LIBOR and meet regulatory timelines.”

BSBY is available as a standalone rate and can also be used as a supplement to Term SOFR.  In addition to BSBY, Bloomberg provides an array of tools and complementary offerings to help market participants transition away from legacy IBORs, including calculating and publishing term and spread adjustments for the fallbacks that ISDA intends to implement for certain IBORs. 

“There is strong demand for a rate that has a term structure and credit component,” commented Peter Tchir, Head of Macro Strategies at Academy Securities. “BSBY is a big step toward incorporating traded rates across a variety of bank issuers to establish a realistic benchmark for transactions; the design fixes a lot of issues and makes it a compelling  alternative as clients prepare for LIBOR transition .”

BSBY will be calculated daily and published at 8 AM ET, using the prior day’s transaction data, on a T+1 basis.  The index can be accessed via the Bloomberg Terminal, and will be posted publicly on Bloomberg.com on a delayed basis.  The index is available for 5 tenors: overnight {BSBYON Index }, 1-month {BSBY1M Index }, 3-months {BSBY3M Index }, 6-months {BSBY6M Index } and 12-months {BSBY12M Index }.  Additional detail on the BSBY methodology can be accessed here.

Bloomberg is licensing BSBY for use as a financial benchmark via Bloomberg Index Services Limited (BISL), Bloomberg’s authorized benchmark administrator. In addition to BSBY, BISL administers the Bloomberg Barclays flagship family of fixed income indices, the Bloomberg Commodity Index (BCOM), and Bloomberg’s Global Equity Index family. BISL provides robust governance and oversight over its benchmark offerings, which will soon include a dedicated oversight function for BSBY composed of a balanced set of market stakeholders.

BSBY’s transaction-based inputs, robust construction and resilient methodology are designed to meet the high standards of both the BMR and the IOSCO principles for financial benchmarks (IOSCO Principles).  An independent assurance report for BSBY’s alignment with the IOSCO Principles will be made available when complete, and BSBY will soon be made available for licensing in additional jurisdictions, including the U.K. and the EU.  More information on BSBY licensing is available here.

About Bloomberg
Bloomberg, the global business and financial information and news leader, gives influential decision makers a critical edge by connecting them to a dynamic network of information, people and ideas. The company’s strength – delivering data, news and analytics through innovative technology, quickly and accurately – is at the core of the Bloomberg Terminal. Bloomberg’s enterprise solutions build on the company’s core strength: leveraging technology to allow customers to access, integrate, distribute and manage data and information across organizations more efficiently and effectively. For more information, visit Bloomberg.com/company or request a demo.

View original content to download multimedia:http://www.prnewswire.com/news-releases/bloombergs-bsby-short-term-credit-sensitive-index-now-available-for-us-loan-market-301241872.html

SOURCE Bloomberg

DUBLIN, Calif., March 8, 2021 /PRNewswire/ — Ross Stores recently opened four Ross Dress for Less^® (“Ross”) and three dd’s DISCOUNTS^® stores across five different states in February and March. These new locations are part of the Company’s plans to add approximately 60 new stores – 40 Ross and 20 dd’s DISCOUNTS locations – during fiscal 2021. 

“These recent openings reflect our ongoing plans to continue the expansion of our two chains,” said Gregg McGillis, Group Executive Vice President, Property Development. “We now operate a total of 1,866 Ross Dress for Less and dd’s DISCOUNTS locations across 40 states, the District of Columbia, and Guam. As we look out over the long-term, we remain confident that Ross can grow to 2,400 locations and dd’s DISCOUNTS can become a chain of 600 stores given consumers’ ongoing focus on value and convenience.”

Forward-Looking Statements:





 This press release contains forward-looking statements regarding projected sales and earnings, planned new store growth, and other financial results and market conditions in future periods that are subject to risks and uncertainties which could cause our actual results to differ materially from management’s current expectations. The words “plan,” “expect,” “target,” “anticipate,” “estimate,” “believe,” “forecast,” “projected,” “guidance,” “outlook,” “looking ahead,” and similar expressions identify forward-looking statements. Risk factors for Ross Dress for Less


^®


 (“Ross”) and dd’s DISCOUNTS


^®


 include without limitation, the uncertainties and potential for further significant business disruptions arising from the ongoing COVID-19 pandemic, including potential distribution center and store closures and restrictions on customer access; changes in the level of consumer spending on or preferences for apparel and home-related merchandise; impacts from the macro-economic environment, financial and credit markets, geopolitical conditions, unemployment levels or public health issues (such as pandemics) that affect consumer confidence and consumer disposable income; our need to effectively manage our inventories, markdowns, and inventory shortage to achieve planned gross margins; competitive pressures in the apparel or home-related merchandise retailing industry; issues from selling and importing merchandise produced in other countries and from supply chain disruptions in other countries, including due to COVID-19 closures; unseasonable weather that may affect shopping patterns and consumer demand for seasonal apparel and other merchandise, and may result in temporary store closures and disruptions in deliveries of merchandise to our stores; market availability, quantity, and quality of attractive brand name merchandise at desirable discounts and our buyers’ ability to purchase merchandise that enables us to offer customers a wide assortment of merchandise at competitive prices; potential data security breaches, including cyber-attacks on our transaction processing and computer information systems, which could result in theft or unauthorized disclosure of customer, credit card, employee, or other private and valuable information that we handle in the ordinary course of our business; potential disruptions in our supply chain or information systems; issues involving the quality, safety, or authenticity of products we sell, which could harm our reputation, result in lost sales, and/or increase our costs; an adverse outcome in various legal, regulatory, or tax matters; damage to our corporate reputation or brands; our need to continually attract, train, and retain associates to execute our off-price strategies; our need to effectively advertise and market our business; changes in U.S. tax, tariff, or trade policy regarding apparel and home-related merchandise produced in other countries that could adversely affect our business; volatility in revenues and earnings; an additional pandemic, natural or man-made disaster in California or in another region where we have a concentration of stores, offices, or a distribution center; unexpected issues or costs from expanding in existing markets and entering new geographic markets; obtaining acceptable new store sites with favorable consumer demographics; and maintaining sufficient liquidity to support our continuing operations, new store openings and reopenings, and ongoing capital expenditure plans. Other risk factors are set forth in our SEC filings including without limitation, the Form 10-K for fiscal 2019, fiscal 2020 Form 10-Qs, and fiscal 2021 Form 8-K on file with the SEC. The factors underlying our forecasts are dynamic and subject to change. As a result, our forecasts speak only as of the date they are given and do not necessarily reflect our outlook at any other point in time. We do not undertake to update or revise these forward-looking statements.

Ross Stores, Inc. is an S&P 500, Fortune 500, and Nasdaq 100 (ROST) company headquartered in Dublin, California, with fiscal 2020 revenues of $12.5 billion. Currently, the Company operates Ross Dress for Less^® (“Ross”), the largest off-price apparel and home fashion chain in the United States with 1,589 locations in 40 states, the District of Columbia, and Guam. Ross offers first-quality, in-season, name brand and designer apparel, accessories, footwear, and home fashions for the entire family at savings of 20% to 60% off department and specialty store regular prices every day. The Company also operates 277 dd’s DISCOUNTS^® in 21 states that feature a more moderately-priced assortment of first-quality, in-season, name brand apparel, accessories, footwear, and home fashions for the entire family at savings of 20% to 70% off moderate department and discount store regular prices every day. Additional information is available at www.rossstores.com.

View original content:http://www.prnewswire.com/news-releases/ross-stores-to-open-60-new-locations-in-2021-301241756.html

SOURCE Ross Stores, Inc.

ATLANTA, March 8, 2021 /PRNewswire/ — Delta Air Lines (NYSE:DAL) will present at the J.P. Morgan Industrials Conference at 8:00 a.m. ET on Mon., Mar. 15, 2021.

A live webcast of this event will be available at ir.delta.com.  An online replay will be available at the same site shortly after the webcast is complete.

View original content to download multimedia:http://www.prnewswire.com/news-releases/delta-air-lines-to-present-at-the-jp-morgan-industrials-conference-301241642.html

SOURCE Delta Air Lines

NEW YORK, March 8, 2021 /PRNewswire/ — Traditional U.S. multichannel plumbed new depths in 2020 with a decline of nearly 7.2 million subscriptions, according to full market estimates from Kagan, a media research group within S&P Global Market Intelligence.

Virtual multichannel services blunted the overall erosion of people taking a package of live linear channels, but the estimated 2.7 million new subscribers for the services that increasingly resemble the traditional services being displaced fell short of offsetting cable, telco and satellite defections.

Losses for those traditional cable, telco and satellite providers slowed in the fourth quarter but the full-year decline underscored that the impacts of the pandemic amplified cord cutting instead of insulating an industry built around home entertainment.

The fourth quarter offered an overall improvement in traditional subscription losses at 1.5 million, but the virtual segment did not maintain the surprising momentum from the third quarter, tallying a tepid estimated gain of 223,000 to finish the year at nearly 12.5 million subscriptions.

“Americans continue to leave traditional video services in droves, with 6.8 million households cutting the cord in 2020,” said Tony Lenoir, senior analyst with Kagan.

Additional penetration takeaways from Kagan’s full year 2020 report:  

• The combined penetration of traditional and virtual subscriptions, which accounts for the total households in the U.S. taking a package of live, linear channels, dropped below 67% at year end.
• The percentage of households in the U.S. with a traditional multichannel subscription dropped to less than 57%.

S&P Global Market Intelligence’s Kagan research team provides in-depth coverage and deep analyses of the global technology, media and telecommunications sectors (TMT). This TMT research offering complements S&P Global Market Intelligence’s broad universe of research sector coverage including energy, enterprise technology, financial institutions groups, leveraged loans, and metals & mining.

S&P Global Market Intelligence’s opinions, quotes, and credit-related and other analyses are statements of opinion as of the date they are expressed and not statements of fact or recommendation to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security.

About S&P Global Market Intelligence
At S&P Global Market Intelligence, we understand the importance of accurate, deep and insightful information. We integrate financial and industry data, research and news into tools that help track performance, generate alpha, identify investment ideas, perform valuations and assess credit risk. Investment professionals, government agencies, corporations and universities around the world use this essential intelligence to make business and financial decisions with conviction.

S&P Global Market Intelligence is a division of S&P Global (NYSE: SPGI), the world’s foremost provider of credit ratings, benchmarks and analytics in the global capital and commodity markets, offering ESG solutions, deep data and insights on critical business factors. S&P Global has been providing essential intelligence that unlocks opportunity, fosters growth and accelerates progress for more than 160 years. For more information, visit www.spglobal.com/marketintelligence.

Media Contact

Amanda Oey

S&P Global | Market Intelligence
Tel: 212-438-1904
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/2020-us-multichannel-video-loss-tops-7-million-virtual-subscription-momentum-slows-in-q4-301241631.html

SOURCE S&P Global Market Intelligence

HERZLIYA, Israel, March 8, 2021 /PRNewswire/ — Cognyte (Nasdaq: CGNT), a global leader in security analytics software that empowers governments and enterprises with Actionable Intelligence for a Safer World™, announced today that it will participate in the upcoming Wedbush Security Conference.

Cognyte’s Chief Executive Officer Elad Sharon and Chief Financial Officer David Abadi will answer questions in a virtual fireside chat at 10:30am ET on March 11^th.

If you are interested in attending the event please email Wedbush at [email protected].

About Cognyte Software
Cognyte (formerly a Verint company) is a global leader in security analytics software that empowers governments and enterprises with Actionable Intelligence for a Safer World™. Our open software fuses, analyzes, and visualizes disparate data sets at scale to help security organizations find the needles in the haystacks. Over 1,000 government and enterprise customers in more than 100 countries rely on Cognyte’s solutions to accelerate security investigations and connect the dots to successfully identify, neutralize, and prevent threats to national security, business continuity, and cyber security. Learn more about how we empower our customers to create a safer world with Actionable Intelligence® at www.cognyte.com.

This press release contains “forward-looking statements,” including statements regarding expectations, predictions, views, opportunities, plans, strategies, beliefs, and statements of similar effect relating to Cognyte Software Ltd. These forward-looking statements are not guarantees of future performance and they are based on management’s expectations that involve a number of risks, uncertainties and assumptions, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. For a detailed discussion of these risk factors, see our registration statement on Form 20-F, and other filings we make with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release and, except as required by law, Cognyte assumes no obligation to update or revise them or to provide reasons why actual results may differ. COGNYTE, ACTIONABLE INTELLIGENCE, and ACTIONABLE INTELLIGENCE FOR A SAFER WORLD are trademarks of Cognyte Software Ltd. or its subsidiaries. Cognyte and other parties may also have trademark rights in other terms used herein.

View original content to download multimedia:http://www.prnewswire.com/news-releases/cognyte-announces-participation-in-upcoming-investor-conference-301241825.html

SOURCE Cognyte